Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
Two former US Food and Drug Administration (FDA) officials have commented on and proposed changes to the agency’s recent ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA's new draft guidance clarifies how companies can gain regulatory validation for their alternative preclinical model.
Several patient and disease advocacy organizations have responded to the Center for Drug Evaluation and Research's (CDER) ...
Pharmaceutical regulatory consulting for drug developers and CROs: IND CMC, method validation, NDA strategy, and FDA ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose assessment to support regulatory decision-making for nonclinical safety data.
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug and chemical safety assessments. The FDA has released draft guidance ...
Process validation is crucial for ensuring the quality of final products and the safety of these processes for manufacturing personnel and consumers in the pharmaceutical, medical device, and ...
In biopharmaceutical manufacturing, consistency is vital but hard to achieve. Turning raw materials into safe, high-quality medicines requires stable processes. However, the living cellular expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results